Belgium vs Bhutan: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
Bhutan
419
in 2021
Belgium rank
86th
Bhutan rank
83rd
The number of people with susceptibility test result for rifampicin over time
- Belgium
- Bhutan
How they compare
Bhutan currently reports 419 against 377 in Belgium, a difference of 42.
That makes Bhutan's figure about 1.1 times Belgium's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belgium ahead.
Belgium ranks 86th and Bhutan ranks 83rd of 155 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Bhutan in 1.
Head to head by decade
| Decade | Belgium | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 400.33 | 29.67 | Belgium |
| 2020s | 348.5 | 426.5 | 78 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or Bhutan?
- Bhutan, at 419 against 377 in Belgium as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and Bhutan?
- 42, with Bhutan ahead.
- How many years of comparable data are there for Belgium and Bhutan?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and Bhutan rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and Bhutan ranks 83rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.